Common challenges in biotech scale-up:
Results from laboratory-scale experiments are not transferable
Business cases are based on unrealistic assumptions
The processes are not sufficiently secured from a technical standpoint
Scale-up and production have not been properly set up
Investor expectations clash with operational uncertainty
The result is delays, rising costs, and a growing loss of trust among stakeholders.
Successful scaling up means managing technical development, financial planning, and market demands all at the same time. This is exactly where Entourage comes in.
We help biotech companies scale their processes in a stable manner, develop realistic business cases, and align investor expectations with operational realities. We combine strategic consulting with operational implementation and focus our efforts precisely where the greatest risks arise.
If you are currently facing the challenge of preparing for or securing your scale-up, it’s worth taking a structured look at the key factors.